Official EU label nameGlossary entry 1121

ADENOSINE

This record confirms an official common ingredient name for EU cosmetic product labelling. It does not by itself confirm that the substance is permitted, unrestricted or safe.

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

Markets with evidence

Evidence gaps

Resolved identifiers

Resolved substance identity

CAS:58-61-7

EC:200-389-9

Ingredient index records:

ADENOSINE

Cosmetic functions: SKIN CONDITIONING

6-Amino-9-beta-D-ribofuranosyl-9H-purine

Open full local profile

2 matched or reported names

ADENOSINEAdenosine [USAN:BAN}

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name ADENOSINE.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 58-61-7

CAS 58-61-7PubChem CID 60961

Adenosine

Adenosine is a ribonucleoside composed of a molecule of adenine attached to a ribofuranose moiety via a betaN9-glycosidic bond. It has a role as an analgesic, a vasodilator agent, an anti-arrhythmia drug, a human metabolite and a fundamental metabolite. It is a purines D-ribonucleoside and a member of adenosines. It is functionally related to an adenine. — ChEBI

IUPAC name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

Molecular formula: C10H13N5O4
Molecular weight: 267.24 g/mol
Exact mass: 267.09675391 Da
XLogP3: -1.1
Topological polar surface area: 140.0 Å²
Hydrogen-bond donors: 4
Hydrogen-bond acceptors: 8
Covalent units: 1
Defined stereocentres: 4

Also known as

AdenocardAdenoscanAdenine ribosideNucleocardylbeta-D-AdenosineBonitonSandesinMyocol

16 more reported names

Adenosinbeta-AdenosineAdenine nucleoside9-beta-D-Ribofuranosyl-9H-purin-6-amineAdenocor9-beta-D-RibofuranosyladenineUSAF CB-109-beta-D-Ribofuranosidoadenine9beta-D-Ribofuranosyladenine6-Amino-9-beta-D-ribofuranosyl-9H-purineAde-RibSR 962256-Amino-9beta-D-ribofuranosyl-9H-purine(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diolAdenin ribosideCHEBI:16335

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:16335
ChEMBL:CHEMBL477
EPA DTXSID:DTXSID1022558
PubMed:34773529
PubMed:34070360
PubMed:32941855
PubMed:29968805
PubMed:29360751
PubMed:28041785
PubMed:27590504
PubMed:27567601
PubMed:27469509
PubMed:27297283
PubMed:27188793
PubMed:25496463

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision